Gene Query: NGEF

Dataset Description Geneva Score
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 40.85
Control of prostate tumour growth by the long non-coding RNA GHSROS 31.53
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 29.93
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 29.66
TGF-β promotes genomic instability after loss of RUNX3 28.01
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 23.58
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 22.92
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 22.87
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 22.87
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 20.16
circRNA-sequencing 19.04
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 18.61
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 18.18
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 18.18
Gene expression profiling of papillary thyroid cancer from central and invasive regions 17.92
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 17.54
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 17.54
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 17.46
MYCi975 regulates MYC target genes 16.11
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 15.75
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 15.75
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 15.59
The Glioma-Infiltrating T Cell Receptor Repertoire 15.46
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 14.35
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 13.32
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 13.26
Silencing SPIB in attached and floating state of H1703 lung cancer cells 13.25
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 12.68
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 12.55
RNA seq comparison between scrambled and shGRP78 cells 12.1
Controlling for gene expression changes in transcription factor protein networks. 11.86
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 11.72
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 11.56
Repurposing of promoters and enhancers during mammalian evolution 11.16
RNA-sequencing of human liver tissue 11.1
Universal alternative splicing of noncoding exons 10.77
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 10.73
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 10.48
RNA-seq of naive and primed ES cells 10.47
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 10.33
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 10.18
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 10.18
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 10.12
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 9.38
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 9.3
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 8.93
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 8.32
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 8.3
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 8.24
Expression profiling of converted and control dermal BJ fibroblasts 8.24
RNA-Seq of the corpus callosum from 12 individuals 8.21
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 8.11
MCF10A H-Ras RNA-Seq 8.05
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 8.04
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 7.97
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 7.87
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 7.61
Rorc disruption in human FG pancreatic cancer cells 7.61
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 7.56
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 7.44
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 7.09
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 6.95
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 6.87
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 6.87
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 6.78
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 6.66
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 6.53
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 6.29
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 6.16
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 6.16
AUF-1 affected genes in human skin cells 5.58
SUV420H2 knockdown in PANC-1 5.57
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 5.46
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.39
RNA sequencing of human pancreatic cancer cell lines 5.37
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 5.3
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 5.3
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 5.22
Differentially expressed genes post knock down of lincDUSP26 5.04
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 5.03
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 5.01
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 5.01
Regulation of highly expressed hCINAP on translatome 4.99
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 4.91
Altering cancer transcriptomes using epigenomic inhibitors 4.91
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 4.84
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 4.82
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 4.8
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.73
MYCi361 regulates MYC target genes 4.66
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 4.65
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 4.58
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 4.58
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 4.56
PNET animal model: new insights (II) 4.41
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 4.37
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 4.32
The age and genomic integrity of neurons after cortical stroke in humans 4.32
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 4.29
Comparing gene expression in iPSC derived RPE from control and AMD donors 4.29
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 4.25
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 4.25
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 4.21
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 4.16
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 4.13
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 4.1
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 4.08
Exploring ILF2 regulatory genes by next-generation sequencing 4.06
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 4.03
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 4.02
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 3.99
Genome-wide chromatin analysis of Ewing sarcoma 3.99
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 3.97
LncRNA-GAS5 negative regulation of YAP-target genes expression 3.89
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 3.87
Evolution of a transcriptional regulator from a transmembrane nucleoporin 3.85
RNA-seq in HepG2 and IMR90 cells 3.85
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 3.83
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.77
Effect of CHKA knockdown on C4-2 cell transcriptome 3.74
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 3.7
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 3.48
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 3.45
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 3.4
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 3.39
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 3.39
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 3.39
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 3.38
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 3.34
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 3.33
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 3.33
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 3.33
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 3.3
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 3.29
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 3.27
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 3.19
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 3.18
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 3.12
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 3.11
CHCHD10 gene KO effect in iPSC drived motor neurons 3.11
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 3.11
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 3.05
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 3.03
Random mono-allelic expression in MECP2-mutated cells 2.96
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 2.94
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 2.94
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 2.94
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 2.94
BMS-470539 on human synovial fibroblasts 2.92
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 2.91
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 2.86
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 2.84
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 2.83
Chromatin-informed inference of transcriptional programs in gynecologic cancers 2.77
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 2.77
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.74
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.74
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 2.73
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 2.73
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 2.71
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 2.68
RNA-seq analyses of human prostate cancer cells 2.65
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 2.58
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.56
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 2.51
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 2.46
Investigate A2M treatment on human prostate cancer xenograft in mice 2.45
Investigate A2M treatment on human prostate cancer and mouse liver 2.45
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 2.43
Glioblastoma stem cells infected by ZIKA virus 2.4
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.38
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.35
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.35
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 2.32
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 2.32
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 2.31
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 2.3
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 2.3
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 2.3
ARID1A and ARID1B loss in HCT116 cells 2.27
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 2.24
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 2.18
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 2.18
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 2.18
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 2.17
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 2.13
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.12
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 2.1
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 2.07
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 2.07
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.06
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 2.05
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 2.05
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 2.05
RNA-Seq analysis of human colorectal cancer with liver metastasis 2.05
Integrin signaling regulates YAP/TAZ to control skin homeostasis 2.03
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 2.03
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.99
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 1.96
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 1.95
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 1.95
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.94
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 1.93
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 1.91
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 1.91
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 1.91
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.88
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 1.88
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.86
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 1.85
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.85
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.85
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 1.85
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 1.85
Single-nucleotide-resolution mapping of HBV promoters using CAGE 1.85
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.84
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.84
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 1.83
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.8
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 1.78
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.73
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 1.72
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 1.71
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.71
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 1.71
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 1.68
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 1.68
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 1.67
AR-independent prostate cancer is sustained through FGF signaling 1.67
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 1.67
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 1.67
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 1.66
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 1.66
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.65
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.64
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.64
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 1.64
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.61
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.6
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 1.6
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 1.6
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.59
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 1.57
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 1.57
RNAseq in Alzheimer's Disease patients 1.57
CHCHD2 gene KO effect in iPSC drived motor neurons 1.56
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 1.56
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.55
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 1.54
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 1.53
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 1.52
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 1.52
Evaluating pre-clinical models for studying NASH driven HCC. 1.52
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 1.51
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.5
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.5
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 1.49
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 1.49
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 1.49
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 1.49
Positively selected enhancer elements endow tumor cells with metastatic competence 1.49
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 1.48
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.48
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.48
Transcriptome profiling of Normal and Cancerous Prostate Cells 1.45
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 1.45
Gene expression changes after LOC550643 silencing 1.45
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.44
Patient-derived xenograft platform for metastatic melanoma 1.44
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.44
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.44
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 1.44
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 1.43
Cajal bodies are linked to genome conformation 1.43
Cajal bodies are linked to genome conformation [RNA-Seq] 1.43
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.43
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.42
CD73 knockdown effect in pancreatic cancer cell lines 1.4
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 1.4
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 1.4
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 1.39
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 1.39
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 1.35
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 1.32
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.31
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.31
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 1.3
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 1.29
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 1.28
Molecular Criteria for Defining the Naive Human Pluripotent State 1.28
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 1.26
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.24
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.24
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 1.24
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 1.24
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 1.24
RNA-seq in endometrial stromal tumors 1.24
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.23
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.22
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 1.21
Paxillin regulates genomic networks in prostate cancer [PC3] 1.21
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 1.21
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 1.21
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.2
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.2
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 1.2
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.2
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 1.19
The effect of Abl kinases on non-small cell carcinoma global transcriptome 1.18
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 1.17
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 1.17
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 1.15
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.13
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 1.12
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 1.12
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.12
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.11
Identification of expressed and conserved human non-coding RNAs 1.09
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 1.04
Functional astrocytes differentiated from hiPSCs 1.03
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 1.03
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 1.03
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 1.02
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 1.02
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 1.02
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 1.01
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 1.0
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 1.0
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 0.99
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 0.99
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 0.98
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.98
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.98
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.97
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 0.96
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 0.95
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 0.94
Transcriptome of EBV-infected gastric cancer cell lines 0.92
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 0.92
iPSC derived motor neuron cultures from C9ORF72 carriers 0.92
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 0.9
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 0.89
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 0.89
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 0.89
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 0.89
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 0.89
JAK dependent survival of ALK- ALCL 0.89
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.87
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.87
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.87
Modulation of nonsense-mediated decay by rapamycin 0.84
PRDM1 inhibits proliferation of human colon cancer organoids 0.84
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 0.83
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 0.83
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.82
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.81
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.81
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.81
Transposon-based construction of strand-specific RNA-seq libraries 0.81
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.8
RNA-sequencing of human tendon after injury 0.8
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.8
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.79
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.79
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.79
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.78
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 0.78
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 0.78
RNA seq analysis of human Fetal and adult derived Enterospheres 0.77
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 0.77
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 0.77
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.77
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.77
Illumina Total RNA-seq in HeLa 0.76
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 0.75
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 0.75
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 0.74
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.73
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.73
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.73
Alteration of the microRNA network during the progression of Alzheimer’s disease 0.73
A549 cell transcriptome responses to infection with H7N9 influenza virus 0.73
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 0.72
The DPYSL2 gene connects mTOR and schizophrenia 0.72
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.71
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.71
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.71
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.71
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.69
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.69
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.69
RNA splicing alteration on glioblastoma and normal neural stem cells 0.69
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.68
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.68
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.68
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.68
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.67
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.64
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 0.64
Single cell transcriptome of peritoneal cells 0.63
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.62
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.61
Iron response of HepG2 cells 0.61
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.61
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 0.6
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 0.6
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 0.59
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.57
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.56
CDK4/6 inhibitor resistance in prostate cancer 0.54
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 0.53
Effect of nuclear IL-33 on gene expression 0.53
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.52
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 0.52
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.51
Overexpression and knockdown experiment for circCSNK1G3 0.5
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 0.49
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 0.49
Gene expression analysis of human hepatocellular cancers 0.49
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.48
Human optic chiasm from healthy controls and multiple sclerosis patients 0.48
Multiple sclerosis and EAE 0.48
RNA-Seq in PWS iPSC-derived neurons 0.47
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.47
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.47
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.47
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 0.47
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 0.46
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.45
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.45
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.45
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 0.45
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.45
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.44
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 0.44
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 0.43
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.42
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.42
RNA-sequencing of healthy human skeletal myocytes 0.42
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.4
RNA-sequencing 0.4
Gene profiling of human adult and pediatric liver cancer cells 0.39
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.39
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.39
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 0.39
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.38
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 0.38
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.38
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.37
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.36
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.35
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  0.33
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.33
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.31
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.31
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.29
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.28
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.28
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 0.28
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 0.28
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.27
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.26
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.25
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.22
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.22
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.22
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.22
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.21
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.2
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.17
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.17
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.17
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.17
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.16
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.13
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.13
Gene expression analysis upon mtDNA depletion 0.12
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.12
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.11
The DNA methylation landscape of human melanoma [RNA-Seq] 0.11
The DNA methylation landscape of human melanoma 0.11
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.1
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.1
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.09
HNRNPM-regulated splicing dependencies in prostate cancer 0.09
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.09
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 0.09
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 0.08
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.08
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.08
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 0.07
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.07
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.06
The contribution of Alu exons to the human proteome 0.04
Gene expression analysis of human adenomas. 0.02
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.02
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.01
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.0
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.0
Cellular response to hepatitis E virus (HEV) infection 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation